» Articles » PMID: 34489434

A Concise Access to Bridged [2,2,1] Bicyclic Lactones with a Quaternary Stereocenter Via Stereospecific Hydroformylation

Overview
Journal Nat Commun
Specialty Biology
Date 2021 Sep 7
PMID 34489434
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Chiral bridged [2,2,1] bicyclic lactones are privileged structural units in pharmaceutics and bioactive nature products. However, the synthetic methods for these compounds are rare. Here we report an efficient method for enantioselective construction of bridged [2,2,1] bicyclic lactones bearing a quaternary stereocenter via Rh-catalyzed asymmetric hydroformylation/intramolecular cyclization/pyridium chlorochromate (PCC) oxidation. By employing a hybrid phosphine-phosphite chiral ligand, a series of cyclopent-3-en-1-ols are transformed into corresponding γ-hydroxyl aldehydes with specific syn-selectivity. Then, hemiacetals form in situ and oxidation with PCC in one-pot affords bridged [2,2,1] bicyclic lactones in high yields and excellent enantiomeric excess. Replacing the hydroxyl group by an ester group, cyclopentanecarbaldehydes with a chiral all-carbon quaternary stereocenter in the γ-position can be generated efficiently.

Citing Articles

Stereoselective Access to Diverse Alkaloid-Like Scaffolds via an Oxidation/Double-Mannich Reaction Sequence.

Mikan C, Watson J, Walton R, Waddell P, Knowles J Org Lett. 2024; 26(26):5549-5553.

PMID: 38905202 PMC: 11232018. DOI: 10.1021/acs.orglett.4c01924.


Construction of a quaternary stereogenic center by asymmetric hydroformylation: a straightforward method to prepare chiral α-quaternary amino acids.

Zhang D, Wen J, Zhang X Chem Sci. 2022; 13(24):7215-7223.

PMID: 35799829 PMC: 9214857. DOI: 10.1039/d2sc02139k.

References
1.
Xie L, Guo H, Lu H, Zhuang X, Zhang A, Wu G . Development and preclinical studies of broad-spectrum anti-HIV agent (3'R,4'R)-3-cyanomethyl-4-methyl-3',4'-di-O-(S)-camphanoyl-(+)-cis-khellactone (3-cyanomethyl-4-methyl-DCK). J Med Chem. 2008; 51(24):7689-96. PMC: 2662438. DOI: 10.1021/jm8003009. View

2.
Xie L, Allaway G, Wild C, Kilgore N, Lee K . Anti-AIDS agents. Part 47: Synthesis and anti-HIV activity of 3-substituted 3',4'-Di-O-(S)-camphanoyl-(3'R,4'R)-(+)-cis-khellactone derivatives. Bioorg Med Chem Lett. 2001; 11(17):2291-3. DOI: 10.1016/s0960-894x(01)00437-1. View

3.
Zhuang X, Deng J, Li H, Kong W, Ruan J, Xie L . Metabolism of novel anti-HIV agent 3-cyanomethyl-4-methyl-DCK by human liver microsomes and recombinant CYP enzymes. Acta Pharmacol Sin. 2011; 32(10):1276-84. PMC: 4010078. DOI: 10.1038/aps.2011.91. View

4.
Johansson P, Back M, Kvarnstrom I, Jansson K, Vrang L, Hamelink E . Potent inhibitors of the hepatitis C virus NS3 protease: use of a novel P2 cyclopentane-derived template. Bioorg Med Chem. 2006; 14(15):5136-51. DOI: 10.1016/j.bmc.2006.04.008. View

5.
Bindra J, Grodski A, Schaaf T, Corey E . New extensions of the bicyclo[2.2.1]heptane route to prostaglandins. J Am Chem Soc. 1973; 95(22):7522-3. DOI: 10.1021/ja00803a061. View